Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1160744
Max Phase: Preclinical
Molecular Formula: C18H25N6O10P
Molecular Weight: 516.40
Molecule Type: Small molecule
Associated Items:
ID: ALA1160744
Max Phase: Preclinical
Molecular Formula: C18H25N6O10P
Molecular Weight: 516.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ccn(C2C[C@@H](O)[C@@H](COP(=O)(O)O[C@@H]3CC(n4ccc(N)nc4=O)O[C@@H]3CO)O2)c(=O)n1
Standard InChI: InChI=1S/C18H25N6O10P/c19-13-1-3-23(17(27)21-13)15-5-9(26)12(33-15)8-31-35(29,30)34-10-6-16(32-11(10)7-25)24-4-2-14(20)22-18(24)28/h1-4,9-12,15-16,25-26H,5-8H2,(H,29,30)(H2,19,21,27)(H2,20,22,28)/t9-,10-,11-,12-,15?,16?/m1/s1
Standard InChI Key: IURHMJAVRZRPAH-MYHPJXBQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 516.40 | Molecular Weight (Monoisotopic): 516.1370 | AlogP: -1.90 | #Rotatable Bonds: 8 |
Polar Surface Area: 236.50 | Molecular Species: ACID | HBA: 15 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.86 | CX Basic pKa: | CX LogP: -3.02 | CX LogD: -5.40 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.24 | Np Likeness Score: 1.06 |
1. Nair V, Pal S.. (2004) Resistance towards exonucleases of dinucleotides with stereochemically altered internucleotide phosphate bonds., 14 (1): [PMID:14684345] [10.1016/j.bmcl.2003.07.034] |
Source(1):